Intradigm Corporation

Develops RNA interference (RNAi) therapeutics for the treatment of cancer.

placePalo Alto, California, United States calendar_todayFounded 2000 groups17 employees language intradigm.com

Registered entities

Investor mix

10 investors on record; lead investors include Astellas Venture Management; 1 has since exited.

Investor typeCountShare
Venture capital440%
Private equity110%
Other / undisclosed550%
Coming soon